Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TGA, Australia announces Ranitidine test results

Posted On: 2019-10-23 16:58:47

Strides Pharma Science Limited (Strides or Company) today shared further updates regarding the supplies of its Ranitidine Tablets. The Company, on September 27, 2019, temporarily suspended the manufacturing and sale of its Ranitidine tablets for the US and Australia markets given the concerns around impurity called N-nitrosodimethylamine (NDMA) which is associated with an increased risk of cancer. As per European Medicines Agency (EMA), NDMA is present in some foods and in water supplies but is not expected to cause harm when ingested in very low levels3.

Summary of the announcement made by Therapeutic Goods Administration, Australia(TGA)1:

- The TGA Laboratories tested samples of Ranitidine medications available in the Australian market.

- A total of 135 batches from 10 Australian companies were tested for NDMA adapting the newly issued US Food and Drug Administration (USFDA) 2 test method using liquid chromatography with high resolution mass spectrometric detection(LC-HRMS).

- TGA has now taken a decision to recall all Ranitidine products with levels of NDMA at or above 0.3 ppm while all batches with levels below 0.3 ppm are available for sale.

Results from the TGA Laboratories Tests

- Out of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have NDMA level at or above the acceptable limit of 0.3 ppm. These batches include 3 batches from Strides supplied to its Australian partner Arrow Pharma Pty Ltd(Arrow).

- Only 24 oral solid dosage batches were found to have levels of NDMA within the acceptable limit of 0.3 ppm of which 20 batches were manufactured by Strides for its partner Arrow with API supplied by Solara Active Pharma Sciences.

Next Steps for Australia

- At Strides, product quality and patient safety is of paramount importance, and we are confident of consistently meeting the acceptable limits of NDMA in Ranitidine.

- Batches manufactured by Strides are now available for sale in Australia through its partner Arrow.

Additional Update on US

- Strides has submitted all requested data to the USFDA in response to the Information Request received on Ranitidine.

- Strides is awaiting further feedback from the USFDA on the NDMA limits for Ranitidine.

Shares of Strides Pharma Science Ltd was last trading in BSE at Rs.342.05 as compared to the previous close of Rs. 350.65. The total number of shares traded during the day was 97027 in over 1664 trades.

The stock hit an intraday high of Rs. 353.75 and intraday low of 336.35. The net turnover during the day was Rs. 33295814.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

The Yamuna Syndicate Ltd reports net profit of Rs. 5.33 crores in Q2

Shaily Engineering Plastics Ltd Q2 net profit improves QoQ

CESC Ltd consolidated Q2 FY20 PAT higher at Rs. 364 crores

R J Shah & Co. Ltd. Q2 net profit at Rs. 0.22 crore

Sakuma Exports Ltd consolidated Q2 net profit up QoQ, drops YoY

Shree Pushkar Chemicals & Fertilisers Ltd consolidated Q2 PAT at Rs. 8.10 crores

Windsor Machines Ltd consolidated PAT drops QoQ

VMS Industries Ltd consolidated Q2 net profit increases QoQ, YoY

Tirupati Sarjan Ltd Q2 PAT up QoQ

Geojit Financial Services Ltd consolidated Q2 FY20 PAT rises to Rs. 9.25 crores

Albert David Ltd posts Rs. 7.92 crores net profit in Q2 FY20

Tyroon Tea Co. Ltd. Q2 net profit increases to Rs. 4.10 crores

PIX Transmissions Ltd Q2 FY20 consolidated net profit higher at Rs. 8.01 crores

PG Foils Ltd posts net profit of Rs. 8.06 crores in Q2

Chartered Capital & Investment Q2 net profit up at Rs. 0.22 crore

EXPO Gas Containers Ltd reports decline in Q2 PAT to Rs. 0.26 crore

Virat Crane Industries Ltd posts net profit of Rs. 1.53 crore in Q2

FACOR Alloys Ltd Q2 consolidated net profit soars to Rs. 13 crores

SMS Lifesciences India Ltd reports drop in consolidated PAT to Rs. 3.68 crores in Q2

Goodluck India Ltd Q2 consolidated PAT drops to Rs. 6.16 crores

Fairchem Specilaity Ltd consolidated Q2 net profit jumps to Rs. 53.75 crores

Vasundhara Rasayans Ltd posts net profit of Rs. 0.45 crore in Q2

Akar Auto Industries Ltd Q2 standalone net profit at Rs. 0.86 crore

Kuantum Papers Ltd Q2 PAT up at Rs. 19.36 crores

Ashiana Ispat Ltd reports net profit of Rs. 0.58 crore

MAAN Aluminium Ltd Q2 PAT rises to Rs. 3.14 crores

TARMAT Ltd Q2 net profit at Rs. 0.41 crore

Vijay Solvex Ltd posts net profit of Rs. 4.86 crores in Q2

Sterling Tools Ltd consolidated Q2 PAT slides to Rs. 7.01 crores

Ishan Dyes & Chemicals Ltd reports Rs. 1.94 crore PAT in Q2 FY20

Archidply Industries Ltd posts higher PAT of Rs. 1.47 crore in Q2

J Kumar Infraprojects Ltd Q2 standalone PAT rises to Rs. 55.90 crores

Vardhman Holdings Ltd Q2 consolidated PAT declines to Rs. 28.88 crores

Jaysynth Dyestuff India Ltd reports net profit of Rs. 0.61 crore in Q2

Future Lifestyle Fashions Ltd consolidated net profit at Rs. 11.87 crores in Q2

Creative Castings Ltd posts Q2 FY2019-20 net profit of Rs. 0.84 crore

Neuland Laboratories Ltd Q2 consolidated PAT jumps to Rs. 8.68 crores

Surya Roshni Ltd posts standalone PAT of Rs. 22.62 crores in Q2

Suryaamba Spinning Mills Ltd posts higher Q2 PAT of Rs. 1.32 crore in Q2

Surbhi Industries Ltd Q2 net profit at Rs. 0.55 crore

Eldeco Housing & Industries Ltd Q2 consolidated PAT at Rs. 8.23 crores

Paul Merchants Ltd consolidated Q2 net profit at Rs. 5.46 crores

Superhouse Ltd Q2 PAT at Rs. 7.60 crores

Jamna Auto Industries Ltd Q2 PAT plunges to Rs. 6.36 crores

Apollo Micro Systems Ltd Q2 PAT slides to Rs. 2.89 crores

Bannari Amman Spinning Mills Ltd posts consolidated PAT of Rs. 4.06 crores in Q2 FY20

IMPAL Q2 consolidated PAT rises to Rs. 15.75 crores

Ganga Papers India Ltd Q2 net profit at Rs. 0.41 crore

Nectar Lifesciences Ltd consolidated Q2 net profit at Rs. 2.45 crores

Action Construction Equipment Ltd Q2 consolidated net profit at Rs. 14.31 crores







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019